Verifying a compounding pharmacy takes about ten minutes and requires no clinical training. Get the pharmacy's legal name, check it on the relevant state board of pharmacy register, establish which compounding pathway it operates under, search FDA's published warning letters for the company name, and confirm the prescriber is named and licensed in your state.
The check is only impossible when a program refuses to name the pharmacy — and that refusal is itself the finding. There is no legitimate reason to withhold from a patient the identity of the facility preparing a weekly injectable for them.
| Check | Why it works | |
|---|---|---|
| 1 | Get the pharmacy's legal name | One question to the program. A name and a state licence number is a good answer; a category is incomplete; a deflection is the answer. |
| 2 | Look it up on the state board register | Free, public, two minutes. Confirms the pharmacy exists and holds a current licence. |
| 3 | Establish the compounding pathway | Patient-specific compounding and registered outsourcing facilities are regulated differently. Neither produces an FDA-approved drug. |
| 4 | Check FDA warning letters | Published and searchable by company name. Enforcement in this market has been active. |
| 5 | Ask about sterility and potency testing | For an injectable, both matter. Willingness to describe the testing program is itself informative. |
| 6 | Confirm the prescriber is named and licensed in your state | Both halves are required. Guaranteed approval before clinical review is disqualifying. |
| 7 | Read the vial label before the first injection | Concentration, volume for your dose, and beyond-use date. Missing any of the three is a reason to call, not to guess. |
Disclosure is not distributed the way you would expect
Price and transparency are close to independent in this market. Some of the cheapest tracked programs publish the most; some of the dearest publish almost nothing. That is why we score the two separately and print both numbers on every review rather than assuming an expensive program has earned trust.
| Program | Disclosure | Pharmacy named | Price at every dose | 12-month |
|---|---|---|---|---|
| Yucca Health | 100/100 | Yes | Yes | $3,096 |
| NexLife | 100/100 | Yes | Yes | $2,580 |
| TrimRx | 85/100 | Not published | Yes | $4,188 |
| SkinnyRx | 85/100 | Not published | Yes | $3,588 |
| MEDVi | 85/100 | Not published | Yes | $4,788 |
| Oak Longevity | 85/100 | Not published | Yes | $2,388 |
| bmiMD | 85/100 | Not published | Yes | $2,796 |
| OnlineSemaglutide.org | 85/100 | Not published | Yes | $4,188 |
| MyStart Health | 85/100 | Not published | Yes | $3,588 |
| Gala Health | 85/100 | Not published | Yes | $3,588 |
| Sprout Health | 85/100 | Not published | Yes | $3,588 |
| Willow | 85/100 | Not published | Yes | $3,588 |
| Strut Health | 85/100 | Not published | Yes | $3,900 |
| Direct Meds | 85/100 | Not published | Yes | $3,360 |
What the red flags actually look like
Guaranteed approval advertised before a clinician has seen your record. Research-use-only labelling, which exists so a seller can argue the product was never intended for injection. No prescription requirement at all. An unnamed pharmacy. No beyond-use date on the vial. Pricing revealed only after you surrender contact details and a health history. Any one of those is enough to walk away, and all of them are visible before you pay.
Why this matters more for compounded products
An FDA-approved product has been reviewed before marketing and made under a federal quality system with full traceability. A compounded preparation has not; its assurance comes from the pharmacy, the state board and, at good operations, batch testing. That framework is legitimate, and it places more of the verification burden on you — which is the honest reason the compounded price is a fraction of the brand price.
If something goes wrong
Keep the vial, the packaging and the shipping record. A quality complaint without physical evidence is very difficult to pursue, and both the pharmacy and the state board will ask for lot information that exists only on the label. Photograph a warm delivery before opening it further, and do not inject while waiting for an answer.
How to Verify a Compounding Pharmacy in Ten Minutes: the shortest useful summary
Tirzepatide is a once-weekly injection titrated from 2.5 mg to a 15 mg ceiling in 2.5 mg steps at intervals of at least four weeks, producing roughly 15 to 21% mean weight reduction across the studied maintenance arms at 72 weeks and about 20% against semaglutide's 14% in the only head-to-head trial. It works while it is taken; the withdrawal evidence shows substantial regain after stopping. Compounded preparations cost from $133 a month and are not FDA-approved; brand product is approved and costs considerably more.
Those five facts decide most questions people arrive with. Everything else on this page is detail underneath them — which is worth reading before you spend $2,388 on a first year, but not worth confusing with the outline.
How to Verify a Compounding Pharmacy in Ten Minutes: where to go next
If you have not chosen a program, price your expected maintenance dose with the projector rather than reading advertisements. If you have, check what it charges at 10 mg against the price-by-dose table. If you are struggling with side effects, the side-effect reference covers each one with reported frequencies and the red flags that need a clinician. And if a program has refused to name its pharmacy, the verification walkthrough explains why that single answer outranks any price difference.
People also ask about verify compounding pharmacy
What is verify compounding pharmacy?
Verify compounding pharmacy is covered in full on this page, with the clinical detail drawn from the tirzepatide prescribing information and the published SURMOUNT and SURPASS trial program, and any price figures drawn from our tracked dataset and dated to their last verification.
Does verify compounding pharmacy apply to compounded tirzepatide as well as Zepbound?
The molecule is the same, so the clinical content applies to both. What differs is regulatory status, dose metering and price: compounded preparations are not FDA-approved, arrive as a multi-dose vial you measure yourself, and cost a fraction of the brand routes.
How much does verify compounding pharmacy cost per month in 2026?
Compounded tirzepatide runs from $133 per month at the entry dose across the 21 compounded programs we track. At a 10 mg maintenance dose the cheapest tracked route is Oak Longevity at $199 per month, or about $2,388 for a first year on the standard escalation. Brand Zepbound through manufacturer self-pay sits well above that and pharmacy retail well above again. Verified 2026-08-05.
Is verify compounding pharmacy FDA-approved?
Brand tirzepatide (Zepbound and Mounjaro) is FDA-approved. Compounded tirzepatide is not: FDA does not approve compounded drugs and does not review them for safety, effectiveness or quality before they are marketed. The active molecule is the same; the regulatory review is not.
Sources
- US prescribing information for tirzepatide (Zepbound and Mounjaro), Eli Lilly and Company.
- SURMOUNT-1 — tirzepatide once weekly for the treatment of obesity, NCT04184622.
- SURMOUNT-5 — tirzepatide versus semaglutide in adults with obesity, NCT05822830.
- US Food and Drug Administration, human drug compounding — compounded drugs are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality before marketing.
- Program pricing as recorded in our open dataset, with a verification date on every record.